维普中文期刊产品整合服务
17篇 您的检索式:作者名="Wohl DA"
    题名 作者 年代 出处 被引量
1Ezetimibe alone re- duces low density lipoprotein cholesterol in HIV-infected patients receiving combination antiretroviral therapy显示文摘Wohl DA Waters D Simpson RJ Jr 2008Clin Infect Dis2008,47,8:1
2A randomized, double-blind comparison of single-tablet regimen elvitegravir/cobicistat/emtricit-abine/tenofovir DF versus single-tablet regimen efavirenz/emtricib abine/tenofovir DF for initial treatment of HIV-I infection : analysis of week 144 results显示文摘Wohl DA Cohen C Gallant JE et a/ 2014J Acquir Immune Defic Syndr2014,65,3:1
3Comparison of cardiovascular disease risk markers in HIV-infected patients receiving abacavir and tenofovir显示文摘Wohl DA Amoczy G Fichtenbaum C J 2014Antivir Ther2014,19,2:1
4Randomized study of thesafety and efficacy of fish oil ( omega-3 fatty acid )supplementation with dietary and exercise counseling for thetreatment of antiretroviral therapy-associated hypertriglyceridemia显示文摘Wohl DA Tien HC Bu^>y M 2005Clin Infect Dis2005,41,10:1
5Stress fracture healing:fatigue loading of the rat ulna induces upregulation in expression of osteogenic and angiogenic genes that mimic the intramembranous portion of fracture repair显示文摘Wohl GR Towler DA Silva MJ 2009Bone2009,44,2:1
6Low rate of CMV end-organ disease in HIV-infeeted patients despite low CD4 + cell counts and CMV viremia: results of ACTG protocol A5030 显示文摘Wohl DA Kendall MA Andersen J 2009HIV Clin Trials2009,10,3:1
7Ezetimibe alone reduces low-density lipoprotein cholesterol in HIV-infected patients receiving combination antiretroviral therapy显示文摘WOHL DA WATERS D SIMPSON RJ Jr 2008Clin Infect Dis2008,47,8:1
8Safety, tolerabliity, and pharmacokinetic effects of thalidomide in patients infected with human immunodeficiency virus: AIDS Clinical Trials Group 267 显示文摘Wohl DA Awecka FT Schmitz J 2002Infect Dis2002,185,9:1
9Antiretroviral therapy:when to start显示文摘Sellers CJ Wohl DA 2014Infect Dis Clin North Am2014,28,3:1
10Low rate of CMV end-organ disease in HIV-infected patients despite low CD4+ cell counts and CMV viremia: resuhs of ACTG protocol A5030 显示文摘Wohl DA Kendall MA Andersen J 2009HIV Clin Trials2009,10,3:1
11Current concepts in the diagnosis and management of metabolic complications of HIV infection and its therapy显示文摘Wohl DA Mccomsey G Tebas P 2006Clin Infect Dis2006,43,5:1
12Risk factors for Kapo-si's sarcoma among HHV-8 Hopositive homosexual men with AIDS显示文摘Mbulaiteye SM Gallant JE Wohl DA 2005Int J Cancer2005,115,:1
13Current concepts in the diagnosis and management of metabolic complications of HIV infection and its therapy显示文摘Wohl DA McComsey G Tebas P 2006Clinical Infectious Diseases2006,43,5:1
14Management of morphologic changes associated with antiretroviral use in HIV-infected patients 显示文摘Wohl DA Brown TT 2008J Acquir Immune Defie Syndr2008,492,:1
15Randomized study of the safety and efficacy of fish oil(omega 3 fatty acid)supplementation with dietary and exercise counseling for the treatment of antiretroviral therapy - associated hypertriglyceridemia显示文摘Wohl DA Tien HC Busby M 2005Clin Infect Dis2005,41,:1
16Low rate of CMV end-organ disease in HIV-infected patients despite low CD4 + cell counts and CMV viremia: results of ACTG proto- col A5030 显示文摘Wohl DA Kendall MA Andersen J 2009HIV Clin Trials2009,10,3:1
17Current conceptsin the diagnosis and management of metabolic complica-tions of HIV infection and its therapy 显示文摘Wohl DA McComsey G Tebas P 2006Clin Infect Dis2006,43,5:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费